Summarized by Masters of Longevity from BioSpace - Funding.
The Research Council of Norway awarded NOK 15.6 million to improve TCR‑NK manufacturing.
Key Takeaways
- A NOK 15.6 million grant was awarded to Zelluna.
- The project is to increase doses per donor and lower costs.
- This funding has not established clinical efficacy or wider access.
